from Dreamers to Disruptors

Man Up to Cancer's Trevor Maxwell on Building Communities and Empowering Patients

A cancer diagnosis is one of the most challenging experiences a person can have. As well as the physical consequences of serious illness, people can find themselves feeli

DTRA's Craig Lipset on Decentralized Trials and Accelerating Rare Disease Research

New technologies have always driven advances in clinical research, and that's still true today. The Covid pandemic rapidly accelerated the adoption of decentralized trial

Medidata NEXT London 2026 LIVE

At its heart, Medidata NEXT is a conversation where leading experts in clinical research come together in open dialogue. Representing the biggest names in healthcare and

Fighting Cancer with External Control Arms: Friends of Cancer Research's Jeff Allen

External Control Arms are a powerful clinical research tool, harnessing cutting-edge tech to fill gaps in clinical data and accelerate trials when patients' lives are on

Medidata NEXT New York 2026 LIVE

NEXT New York is our flagship event, bringing together the world's leading life sciences companies and thinkers to envision a transformative future for healthcare that ch

Investing in the Future of Healthcare: 7wire Ventures' Lee Shapiro

As a veteran entrepreneur in life sciences, Lee Shapiro has invested in some of the most transformative technologies in modern healthcare history—developing a deep unders

Life Sciences Innovation in 2026: Predictions and Goals

As we enter the new year, the mandate is clear: evolve clinical research or get left behind. Join us to revisit conversations between Medidata CEO Anthony Costello and

How Drug Repurposing Unlocks New Uses for Existing Medicines: Every Cure's David Fajgenbaum

David Fajgenbaum's relationship to drug repurposing is personal, professional, and one of the most inspiring stories in modern medicine. Diagnosed with Castleman disease

The Challenges of Clinical Trial Digitization and The Digital Medicine Society (DiMe) Mission: Jennifer Goldsack

Jennifer Goldsack has made it her mission to push the boundaries of how technology can enhance healthcare. As founder and CEO of the Digital Medicine Society (DiMe), she

Patient-centric Clinical Trials, from Sign-up to Treatment: IQVIA's Tracy Mayer

Patient-centric trials are essential for the future of clinical development, but there are hurdles to overcome. The industry must adapt to the needs and preferences of pa

Prescription Digital Therapeutics, from Trials to Treatment: Click Therapeutics' David Benshoof Klein

Digital therapeutics are poised to transform healthcare as we know it, delivering Software-Enhanced Drugs™ to patients that extend and expand on traditional treatments, a

AI Ethics, Patient Recruitment, and a New Vision for Clinical Data: Arnaub Chatterjee

When it comes to understanding the application and potential of AI in clinical trials, you're unlikely to find a greater expert than Arnaub Chatterjee, Datavant's GM and

AI, Decentralized Clinical Trials, and Paving the Way for New Technologies in Pharma: Marisa Co

Marisa Co has built a career based on intimate knowledge of every aspect of the pharmaceutical industry, giving her unparalleled insight into clinical trials and how to d

Alzheimer's Treatments, Dementia Early Detection, and the Future of Central Nervous System Research: Brad O'Connor

As life expectancy increases and survival rates for cancer and heart disease improve, central nervous system (CNS) conditions are increasingly becoming a focus in healthc

Women's Health, Digital Therapeutics, and Driving Change in Pharma: Jessica Federer

As Bayer's first Chief Digital Officer, Jessica Federer is a true pioneer in life sciences. An early driver of digital transformation in clinical research and a champion